Literature DB >> 338202

Homogeneous enzyme immunoassay for cannabinoids in urine.

R Rodgers, C P Crowl, W M Eimstad, M W Hu, J K Kam, R C Ronald, G L Rowley, E F Ullman.   

Abstract

We describe a homogeneous enzyme immunoassay for measurement of cannabinoid metabolites, as well as delta9-tetrahydrocannabinol (I) in urine. Malate dehydrogenase from pig heart mitochondria was labeled with a derivative of I. The compound used to calibrate the assay was the I metabolite, 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid (II). With 15 microgram of II per liter of urine as the cutoff concentration, the assay can detect 25 microgram of II per liter with greater than 95% confidence. A positive response was obtained for urine specimens assayed within 30 min after exposure to cannabinoids. However, the persistence of metabolites of I in urine indicates that assay of this fluid is useful as an indicator of cannabinoid use but not as an indicator of intoxication.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 338202

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Recent advances in homogeneous and separation-free enzyme immunoassays.

Authors:  T T Ngo; H M Lenhoff
Journal:  Appl Biochem Biotechnol       Date:  1981-03       Impact factor: 2.926

2.  Anti-inflammatory effects of recreational marijuana in virally suppressed youth with HIV-1 are reversed by use of tobacco products in combination with marijuana.

Authors:  John W Sleasman; Maureen M Goodenow; Li Yin; Ashok R Dinasarapu; Samiksha A Borkar; Kai-Fen Chang; Kristina De Paris; Julie J Kim-Chang
Journal:  Retrovirology       Date:  2022-05-31       Impact factor: 3.768

3.  [Tetrahydrocannabinols in hair of hashish smokers].

Authors:  S Balabanova; P J Arnold; V Luckow; H Brunner; H U Wolf
Journal:  Z Rechtsmed       Date:  1989

4.  Maternal marijuana use and neonatal outcome: uncertainty posed by self-reports.

Authors:  R Hingson; B Zuckerman; H Amaro; D A Frank; H Kayne; J R Sorenson; J Mitchell; S Parker; S Morelock; R Timperi
Journal:  Am J Public Health       Date:  1986-06       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.